Determining the Molecular Mechanism of a Caulobacter DNA Replication Checkpoint

确定柄杆菌 DNA 复制检查点的分子机制

基本信息

  • 批准号:
    8905320
  • 负责人:
  • 金额:
    $ 5.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-04-01 至 2018-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Cellular proliferation in all organisms requires the sequential execution of DNA replication, chromosome segregation, and cell division. To coordinate these activities, cells employ regulatory "checkpoints" that ensure faithful completion of each step before attempting the next. Although the cell cycle has been well studied in eukaryotes, our understanding of cell cycle networks and regulatory controls in bacteria remains rudimentary. Caulobacter crescentus represents an excellent model for studies of cell cycle control in bacteria as it is genetically tractable, easily synchronized, and exhibits distinct G1, , and G2 phases. C. crescentus exhibits a DNA replication checkpoint, such that when DNA replication is blocked, cell cycle progression halts. Previous work demonstrated that DNA replication initiation somehow promotes activation of CtrA, an essential cell cycle regulator. CtrA is a response regulator of the two-component signaling protein family that, when phosphorylated, acts as a global transcription factor, promoting expression of genes necessary for cell division. In the absence of DNA replication, CtrA is not activated, thus ensuring that cels do not attempt cell division prematurely. However, the molecular mechanism underlying this critical cell cycle checkpoint remains unknown and is the focus of this project. High-throughput candidate and unbiased genetic approaches will be used to identify potential regulators necessary for coupling CtrA regulation to DNA replication. The candidate regulators identified in these screens will be tested alongside one previously identified CtrA regulator for their roles in linking DNA replication to CtrA activation. Genetic and biochemical approaches will be used to distinguish how these regulators promote activation of CtrA in a DNA replication-dependent manner. Thus, the results from this study will provide important insights into the regulatory mechanisms coupling DNA replication to cell cycle progression in bacteria. Studies of the bacterial cell cycle are important as they (1) can reveal regulatory principles conserved in all domains of life and (2) will reveal critical differences that could be exploited to develop new antibiotics.
 描述(由申请方提供):所有生物体中的细胞增殖需要依次执行DNA复制、染色体分离和细胞分裂。为了协调这些活动,细胞使用监管“检查点”,以确保在尝试下一个步骤之前忠实地完成每个步骤。尽管细胞周期在真核生物中已经得到了很好的研究,但我们对细菌中细胞周期网络和调节控制的了解仍然很初步。新月柄杆菌是研究细菌细胞周期控制的一个很好的模型,因为它在遗传上是易处理的,容易同步化,并表现出不同的G1,和G2期。C. crescentus具有DNA复制检查点,因此当DNA复制被阻断时,细胞周期进程停止。以前的工作表明,DNA复制起始以某种方式促进CtrA的激活,CtrA是一种重要的细胞周期调节因子。Ctra 是双组分信号蛋白家族的反应调节因子,当磷酸化时,作为全局转录因子,促进细胞分裂所需基因的表达。在没有DNA复制的情况下,CtrA不会被激活,从而确保CtrA不会过早地尝试细胞分裂。然而,这个关键的细胞周期检查点的分子机制仍然未知,是这个项目的重点。高通量的候选人和公正的遗传方法将被用来确定耦合CtrA调节DNA复制所需的潜在监管机构。在这些筛选中确定的候选调节器将与先前确定的CtrA调节器一起测试它们在将DNA复制与CtrA激活联系起来中的作用。遗传和生物化学的方法将被用来区分这些监管机构如何促进激活的CtrA在DNA复制依赖的方式。因此,这项研究的结果将为细菌中DNA复制与细胞周期进程的调控机制提供重要的见解。对细菌细胞周期的研究很重要,因为它们(1)可以揭示在所有生命领域中保守的调控原则,(2)将揭示可用于开发新抗生素的关键差异。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jayme Dyer其他文献

Jayme Dyer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jayme Dyer', 18)}}的其他基金

Determining the Molecular Mechanism of a Caulobacter DNA Replication Checkpoint
确定柄杆菌 DNA 复制检查点的分子机制
  • 批准号:
    9057380
  • 财政年份:
    2015
  • 资助金额:
    $ 5.6万
  • 项目类别:

相似海外基金

DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
  • 批准号:
    EP/Y023528/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.6万
  • 项目类别:
    Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
  • 批准号:
    BB/Y007611/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.6万
  • 项目类别:
    Research Grant
Hitting bacteria with a Bam: Lectin-Like Antimicrobials as New Antibiotics
用 Bam 击中细菌:凝集素类抗菌剂作为新型抗生素
  • 批准号:
    DP230102150
  • 财政年份:
    2023
  • 资助金额:
    $ 5.6万
  • 项目类别:
    Discovery Projects
Systematic identification of synthetic interactions in bacteria towards the next-generation of antibiotics
系统鉴定细菌与下一代抗生素的合成相互作用
  • 批准号:
    468567
  • 财政年份:
    2022
  • 资助金额:
    $ 5.6万
  • 项目类别:
    Operating Grants
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
  • 批准号:
    FL210100071
  • 财政年份:
    2022
  • 资助金额:
    $ 5.6万
  • 项目类别:
    Australian Laureate Fellowships
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
  • 批准号:
    10708102
  • 财政年份:
    2022
  • 资助金额:
    $ 5.6万
  • 项目类别:
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
  • 批准号:
    10587015
  • 财政年份:
    2022
  • 资助金额:
    $ 5.6万
  • 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
  • 批准号:
    10581945
  • 财政年份:
    2021
  • 资助金额:
    $ 5.6万
  • 项目类别:
Developing novel antibiotics from natural products against resistant bacteria
从天然产物中开发针对耐药细菌的新型抗生素
  • 批准号:
    2599490
  • 财政年份:
    2021
  • 资助金额:
    $ 5.6万
  • 项目类别:
    Studentship
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
  • 批准号:
    10358855
  • 财政年份:
    2021
  • 资助金额:
    $ 5.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了